Pivotal bioVenture Partners Investment Advisor LLC - Q1 2022 holdings

$211 Million is the total value of Pivotal bioVenture Partners Investment Advisor LLC's 11 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 10.0% .

 Value Shares↓ Weighting
KRTX  KARUNA THERAPEUTICS INC$108,115,000
-3.2%
852,7080.0%51.15%
+9.5%
PCVX  VAXCYTE INC$26,842,000
+1.5%
1,111,4850.0%12.70%
+14.9%
 RALLYBIO CORP$15,854,000
-26.8%
2,271,3110.0%7.50%
-17.2%
FUSN  FUSION PHARMACEUTICALS INC$12,419,000
+90.8%
1,598,3770.0%5.88%
+115.9%
 EXSCIENTIA PLCads$11,121,000
-27.1%
772,2850.0%5.26%
-17.5%
ARQT  ARCUTIS BIOTHERAPEUTICS INC$10,960,000
-7.1%
569,0410.0%5.19%
+5.1%
AKUS  AKOUOS INC$8,522,000
-44.1%
1,794,0880.0%4.03%
-36.8%
INZY  INOZYME PHARMA INC$6,508,000
-40.0%
1,591,1540.0%3.08%
-32.2%
BOLT  BOLT BIOTHERAPEUTICS INC$5,183,000
-44.1%
1,891,4670.0%2.45%
-36.7%
NewVIGIL NEUROSCIENCE INC$3,941,000560,595
+100.0%
1.86%
ALGS  ALIGOS THERAPEUTICS INC$1,885,000
-81.9%
876,5480.0%0.89%
-79.5%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
KARUNA THERAPEUTICS INC12Q3 202365.4%
VAXCYTE INC12Q3 202319.5%
INOZYME PHARMA INC12Q3 202310.8%
ARCUTIS BIOTHERAPEUTICS INC12Q3 20236.2%
FUSION PHARMACEUTICALS INC12Q3 20236.2%
ALIGOS THERAPEUTICS INC12Q3 20238.0%
BOLT BIOTHERAPEUTICS INC11Q3 202320.0%
RALLYBIO CORP9Q3 202314.1%
AKOUOS INC8Q3 202211.7%
EXSCIENTIA PLC8Q3 20236.4%

View Pivotal bioVenture Partners Investment Advisor LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR2023-11-13
13F-HR2023-08-11
13F-HR2023-05-12
13F-HR2023-02-13
13F-HR2022-11-10
13F-HR2022-08-12
13F-HR2022-05-13
13F-HR2022-02-14
13F-HR2021-11-15

View Pivotal bioVenture Partners Investment Advisor LLC's complete filings history.

Compare quarters

Export Pivotal bioVenture Partners Investment Advisor LLC's holdings